Health ❯ Healthcare ❯ Clinical Trials ❯ Phase 3 Trials

Efficacy and Safety

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

The once-daily peptide offers biologic-like efficacy without injections.

FDA Approves One-Time Intrathecal Gene Therapy Itvisma for Older SMA Patients